Use of faropenem as an indicator of carbapenemase activity in the Enterobacteriaceae.

Day, Kathryn M; Pike, Rachel; Winstanley, Trevor G; Lanyon, Clare; Cummings, Stephen P; Raza, Muhammad W; Woodford, Neil; Perry, John D

Day, Kathryn M; Pike, Rachel; Winstanley, Trevor G; Lanyon, Clare; Cummings, Stephen P; Raza, Muhammad W; Woodford, Neil; Perry, John D.

Affiliation

Day KM; Microbiology Department, Freeman Hospital, Newcastle upon Tyne, United Kingdom.

J Clin Microbiol ; 51(6): 1881-6, 2013 Jun.

Article in En | MEDLINE | ID: mdl-23576544

Subject(s)

Anti-Bacterial Agents/pharmacology; Bacterial Proteins/metabolism; Enterobacteriaceae/drug effects; Enterobacteriaceae/enzymology; beta-Lactamases/metabolism; beta-Lactams/pharmacology; Enterobacteriaceae/isolation & purification; Enterobacteriaceae/metabolism; Enterobacteriaceae Infections/microbiology; Humans; Microbial Sensitivity Tests/methods; Sensitivity and Specificity; United Kingdom

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Bacterial Proteins / Beta-Lactamases / Beta-Lactams / Enterobacteriaceae / Anti-Bacterial Agents Type of study: Diagnostic_studies / Evaluation_studies Limits: Humans Country/Region as subject: Europa Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google